Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Sullivan

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 11, 2017
Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid DependenceVerena E Metz, Jermaine D Jones, Jeanne Manubay, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
Substance Use : Research and Treatment|September 30, 2024
Treatment Journey and Healthcare Resource Use Among Patients With Alcohol Use Disorder Who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs DataRegina Grebla, Jieruo Liu, Amy K O'Sullivan, et al.
The American Journal on Addictions|April 6, 2006
Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trialMaria A Sullivan, Jami L Rothenberg, Suzanne K Vosburg, et al.
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experimentAdam C Brooks, Sandra D Comer, Maria A Sullivan, et al.
Pain|May 28, 2013
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodonePerrine Roux, Maria A Sullivan, Julien Cohen, et al.
Drug Safety|December 1, 2020
Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018Priya Jain, Kimberley McKinnell, Rose Marino, et al.
Drug and Alcohol Dependence|April 21, 2018
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trialAdam Bisaga, Paolo Mannelli, Miao Yu, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 11, 2017
Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid DependenceVerena E Metz, Jermaine D Jones, Jeanne Manubay, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
Substance Use : Research and Treatment|September 30, 2024
Treatment Journey and Healthcare Resource Use Among Patients With Alcohol Use Disorder Who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs DataRegina Grebla, Jieruo Liu, Amy K O'Sullivan, et al.
The American Journal on Addictions|April 6, 2006
Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trialMaria A Sullivan, Jami L Rothenberg, Suzanne K Vosburg, et al.
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experimentAdam C Brooks, Sandra D Comer, Maria A Sullivan, et al.
Pain|May 28, 2013
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodonePerrine Roux, Maria A Sullivan, Julien Cohen, et al.
Drug Safety|December 1, 2020
Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018Priya Jain, Kimberley McKinnell, Rose Marino, et al.
Drug and Alcohol Dependence|April 21, 2018
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trialAdam Bisaga, Paolo Mannelli, Miao Yu, et al.
Pageof 9